Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

How gonorrhea steals iron and blinds your immune system

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Catching gonorrhea does not protect you from catching it again. People are reinfected repeatedly, sometimes within months, and after more than a century of trying there is still no vaccine.

The reasons are specific and worth knowing. This bacterium has three tricks that between them defeat nearly everything the immune system tries.

Illustration of purple, coffee-bean shaped Neisseria gonorrhoeae bacteria in pairs across the red surface of an inflamed mucous membrane.
Neisseria gonorrhoeae always travels in pairs, which is why it is called a diplococcus. Sitting on an inflamed lining like this, it pulls iron straight off the body's own iron-carrying proteins and changes its surface coat often enough that the immune system keeps losing track of it.Illustration created for OwieClear. A drawing, not a photograph of a real sample.

Related pages: Gonorrhea

The bottom line

What we know
  • N. gonorrhoeae takes iron directly from human transferrin and lactoferrin using custom surface receptors.
  • It constantly changes its surface proteins, so antibodies made against it quickly become useless.
  • It survives inside neutrophils, the cells sent to destroy it.
  • Infection produces little or no lasting immunity, and reinfection is common.
What is still open
  • Whether a vaccine is possible. A meningococcal B vaccine appears to give partial protection, which has revived interest.
  • How much of the lack of immunity is evasion and how much is the immune system being actively misdirected.

The story, step by step

  1. 1. Iron piracy ()
  2. 2. Changing uniform ()
  3. 3. Inside the killer ()
  4. 4. No immunity ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 4

It pulls iron straight out of your transport proteins

Lab or animal study

What happens

Iron is essential for bacteria to grow. The human body defends itself by keeping almost no free iron available, locking it inside transport proteins: transferrin in blood and lactoferrin in mucus and secretions. This is called nutritional immunity.

What the research shows

  • N. gonorrhoeae makes surface receptors, TbpA and TbpB, that clamp directly onto human transferrin.
  • A second set, LbpA and LbpB, does the same with lactoferrin.
  • The receptor extracts the iron atom and pulls it inside, leaving the human protein behind.
  • These receptors are specific to human versions of these proteins, which is part of why this bacterium infects only humans.

Why it matters

The body's main strategy for starving bacteria simply doesn't work here. The defense has been turned into a delivery service.

What's still uncertain

  • Because these receptors are essential and relatively consistent, they are being studied as vaccine targets.

Read more

Next: Changing uniform

Part 2 of 4

It changes its surface faster than you can make antibodies

Lab or animal study

What happens

Making antibodies against a new bacterium takes the immune system a week or two. The gonococcus uses that time.

What the research shows

  • It carries silent copies of its pilus gene and swaps pieces between them, producing pili with constantly changing surfaces. This is antigenic variation.
  • It also switches whole genes on and off at random as it divides, so a population contains cells with many different surface combinations. This is phase variation.
  • The Opa proteins are switched this way too, with around a dozen variants available.
  • By the time antibodies against one version exist, the bacteria have moved on.

Why it matters

This is the main reason infection gives no lasting immunity and the main obstacle to a vaccine: there is no stable target to aim at.

What's still uncertain

  • Which surface components are stable enough to be vaccine targets is an active research question.

Read more

Next: Inside the killer

Part 3 of 4

It survives inside the white blood cells sent to destroy it

Lab or animal study

What happens

Neutrophils kill bacteria by swallowing them and dousing them in reactive oxygen compounds, a chemical burst that works like bleach.

What the research shows

  • N. gonorrhoeae makes catalase and superoxide dismutase, enzymes that neutralize those compounds.
  • Live bacteria have been recovered from inside neutrophils in gonorrheal pus.
  • In effect, the immune cell becomes a vehicle rather than an executioner.
  • Some researchers think this also helps the bacteria spread to new sites.

Why it matters

The classic sign of gonorrhea under a microscope is bacteria sitting inside white blood cells. That image is the infection winning, not losing.

What's still uncertain

  • How much of the bacterial population survives this way, versus being killed, is debated.

Read more

Next: No immunity

Part 4 of 4

Why you can catch it again and again

Large observational study

What happens

The practical consequence of all this.

What the research shows

  • Having had gonorrhea gives little or no protection against getting it again.
  • Reinfection within months is common, which is why retesting at 3 months is advised after treatment.
  • The bacterium also appears to actively steer the immune response away from the kind of memory that would protect.
  • No licensed gonorrhea vaccine exists, though a vaccine for meningococcal B, a close relative, appears to give partial protection and is being studied for this.

Why it matters

Treatment cures the current infection and nothing more. Partner treatment and retesting are not bureaucracy; they are the only things that stop the cycle.

What's still uncertain

  • How much protection the meningococcal B vaccine gives, and for how long, is still being established.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.